Eligibility Prostate Cancer NCT01191099

Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with biopsy-proven adenocarcinoma of the prostate who are to be treated with radical prostatectomy at the department of urology, university hospital of zurich
Beskrivning

ID.1

Datatyp

boolean

written informed consent
Beskrivning

ID.2

Datatyp

boolean

Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
metastatic prostate cancer
Beskrivning

ID.3

Datatyp

boolean

contraindications to the class of investigational product under study, e.g. known hypersensitivity or allergy to the investigational product
Beskrivning

ID.4

Datatyp

boolean

severe heart or lung disease
Beskrivning

ID.5

Datatyp

boolean

severe liver or kidney dysfunction
Beskrivning

ID.6

Datatyp

boolean

severe stridor
Beskrivning

ID.7

Datatyp

boolean

distant metastases
Beskrivning

ID.8

Datatyp

boolean

concurrent treatment for other malignant disease
Beskrivning

ID.9

Datatyp

boolean

prior hormonal therapy or radiotherapy
Beskrivning

ID.10

Datatyp

boolean

Similar models

Eligibility Prostate Cancer NCT01191099

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
patients with biopsy-proven adenocarcinoma of the prostate who are to be treated with radical prostatectomy at the department of urology, university hospital of zurich
boolean
ID.2
Item
written informed consent
boolean
Item Group
C0680251 (UMLS CUI)
ID.3
Item
metastatic prostate cancer
boolean
ID.4
Item
contraindications to the class of investigational product under study, e.g. known hypersensitivity or allergy to the investigational product
boolean
ID.5
Item
severe heart or lung disease
boolean
ID.6
Item
severe liver or kidney dysfunction
boolean
ID.7
Item
severe stridor
boolean
ID.8
Item
distant metastases
boolean
ID.9
Item
concurrent treatment for other malignant disease
boolean
ID.10
Item
prior hormonal therapy or radiotherapy
boolean